Cartesian Therapeutics secures loan financing from K2 HealthVentures
Cartesian Therapeutics entered into a Loan and Security Agreement with K2 HealthVentures LLC as lender and administrative agent, dated May 22, 2026. The financing arrangement provides debt capital for the biopharmaceutical company's operations and development activities.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day